![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 18, 15546-15551, May 3, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Sealy Center for Molecular Science, University of Texas
Medical Branch, Galveston, Texas 77555-1061
Received for publication, December 19, 2001, and in revised form, February 12, 2002
Rev1 protein of Saccharomyces
cerevisiae functions with DNA polymerase The REV1- and RAD30-encoded proteins of
Saccharomyces cerevisiae are members of the Y family of DNA
polymerases (1). All of the proteins in this family share five highly
conserved motifs from I to V, but they differ in their ability to
promote replication through DNA lesions (2, 3). By contrast to the
RAD30-encoded DNA polymerase The Rev1 and Rad30 proteins differ also in the manner in which they
contribute to the replication of UV-damaged DNA. Whereas Rev1 functions
with the REV3, REV7-encoded DNA polymerase The mutagenic bypass of abasic sites also requires Rev1 and Pol To provide for a better understanding of the biochemical activity of
Rev1 protein, here we employ steady-state kinetic analyses to examine
the efficiency of nucleotide incorporation by this protein on undamaged
and damaged DNA templates.
Proteins and DNA Substrates--
S. cerevisiae Rev1
protein in fusion with glutathione S-transferase (8)
was expressed in the yeast strain LY2 and purified on a
glutathione-Sepharose 4B column followed by MiniS (Amersham Biosciences) chromatography as described previously (18).
Oligonucleotides were synthesized by Midland Certified Reagent Co.
(Midland, TX). DNA substrates (S1-) were generated by annealing a
52-nucleotide (nt)-long oligonucleotide template 5'-TTC GTA TAA TGC CTA
CAC TXG AGT ACC GGA GCA TCG TCG TGA CTG GGA AAA C-3', which
contained a G (S1-G), an A (S1-A), a T (S1-T), a C (S1-C), or an abasic site (a tetrahydrofuran moiety) (S1-AP) at position 20 (X)
to the 32-nt 5' 32P-labeled oligonucleotide primer N4456,
5'-GTT TTC CCA GTC ACG ACG ATG CTC CGG TAC TC-3'. DNA substrates (S2-)
were generated by annealing a 75-nt oligomer template 5'-AGC TAC CAT
GCC TGC CTC AAG AAT TCG TAA XAT GCC TAC ACT GGA GTA CCG GAG
CAT CGT CGT GAC TGG GAA AAC-3' containing a G (S2-G), a uracil (S2-U),
an abasic site (S2-AP), a 7,8-dihydro-8-oxoguanine (S2-8oxoG), or a
O6-methylguanine (S2-m6G) at position
31 (X) to the 5'-32P-labeled oligonucleotide
primer N4309, 5'-GTT TTC CCA GTC ACG ACG ATG CTC CGG TAC TCC AGT GTA
GGC AT-3'. For DNA substrates shown in Fig. 1B, the 75-nt
template used for generating the substrate S2-G was annealed to the
5'-32P-labeled oligonucleotide primer N4577, 5'-GTT TTC CCA
GTC ACG ACG ATG CTC CGG TA-3', yielding substrate S3, or this template was annealed to the 5'-32P-labeled oligonucleotide primer
N4265, 5'-GTT TTC CCA GTC ACG ACG ATG CTC CGG TAC TCC AGT GTA GG-3',
yielding substrate S4. S5 DNA substrate (Fig. 2) was generated by
annealing a 43-nt oligonucleotide template, 5'-GGG GGG GGG GGG AGT ACC
GGA GCA TCG TCG TGA CTG GGA AAA C-3', to the 5'-32P-labeled
oligonucleotide primer N4456.
Deoxynucleotide Incorporation Assays--
A standard primer
extension reaction (10 µl) contained 40 mM Tris-HCl (pH
7.5), 8 mM MgCl2, 1 mM
dithiothreitol, 100 µg/ml bovine serum albumin, 10% glycerol, 10 nM 5'-32P-labeled oligonucleotide primer
annealed to an oligonucleotide template, 100 µM of a
single or each of all four dNTPs, and 1-5 nM GST-Rev1
protein. In Figs. 1B and 2, instead of the Tris buffer, the
reactions were carried out in a phosphate buffer containing 25 mM potassium phosphate (pH 7.4), 6 mM
MgCl2, 1 mM dithiothreitol, 100 µg/ml bovine
serum albumin, 10% glycerol. Assays were assembled on ice, incubated
at 30 °C for 10 min, and stopped by the addition of loading buffer
(40 µl) containing EDTA (20 mM), 95% formamide, 0.3%
bromphenol blue, 0.3% cyanol blue. The reaction products were resolved
on 10% polyacrylamide gels containing 8 M urea. The
quantitation of the results was done using a Molecular Dynamics STORM
PhosphorImager and ImageQuant software.
Processivity Assays--
Rev1 (3 nM) was
preincubated with the DNA substrate (10 nM) in phosphate
buffer that contained no deoxynucleotides for 5 min at 30 °C.
Reactions were initiated by adding all four deoxynucleotides at
increasing concentration (0.5-100 µM each) or all four
deoxynucleotides plus 100-fold excess of nonradiolabeled DNA substrate
as a trap followed by 10-min incubation at 30 °C. To demonstrate the
effectiveness of the trap, Rev1 was preincubated with the DNA trap and
the primer-template substrate before the addition of dNTPs. The
processivity of Rev1 at 100 µM dNTP concentration was
calculated as described previously (20). Gel band intensities
(In) of the deoxynucleotide incorporation products were
quantitated at each band position (n). Processivity is defined as the
probability, Pn, that the enzyme will incorporate
the next deoxynucleotide rather than dissociating. The
processivity of Rev1 at a particular band position was calculated by
using the equation: Pn = (In+1 + In+2 + ... )/(In + In+1 + In+2 + ... ).
Analysis of Steady-state Kinetics--
Steady-state kinetic
analyses for deoxynucleotide incorporation opposite undamaged G, A, T,
and C residues or an abasic site, a 8-oxoG, or a m6G were performed as
described previously (21, 22). Rev1 (1 nM) was incubated
with 10 nM DNA substrate in the presence of increasing
concentrations of a single deoxynucleotide for 10 min in a Tris buffer.
Gel band intensities of the substrates and products were quantitated by
PhosphorImager, and the observed rate of deoxynucleotide incorporation
was plotted as a function of dNTP concentration. The data were fit by
nonlinear regression using SigmaPlot 5.0 to the Michaelis-Menten
equation describing a hyperbola, v = (Vmax × [dNTP]/(Km + [dNTP]). Apparent Km and
Vmax steady-state parameters were obtained from the fit and were used to calculate the efficiency of deoxynucleotide incorporation (kcat/Km).
Nucleotide Incorporation by Rev1--
First we examined whether
Rev1, besides its deoxycytidyltransferase activity, is able to
incorporate other nucleotides opposite various undamaged and damaged
template residues. DNA substrates containing a different template
nucleotide at the primer:template junction were incubated with Rev1 in
the presence of just one dNTP (Fig.
1A). Rev1 protein incorporated
a C residue across from each of the four undamaged template nucleotides
and also with various efficiencies opposite uracil, 8-oxoG, m6G, and
abasic site. Whereas the C residue was incorporated most readily
opposite template G, Rev1 also incorporated the other nucleotides G, A, and T opposite template G (Fig. 1A, lanes 1-4).
Because yeast Rev1 was shown to have only a deoxycytidyltransferase
activity in the previous study (8), we examined the dependence of these other nucleotide incorporations by Rev1 on the sequence context and on
the Tris buffer we used instead of the phosphate buffer employed in the
previous study. The incorporation by Rev1 of each of four
deoxynucleotides opposite a template G residue present in two other
sequence contexts was examined in phosphate buffer (Fig.
1B). Here also, Rev1 incorporated all four nucleotides
opposite template G; however, the level of incorporation of the G, A,
and T nucleotides varied depending on the sequence context of the template (Fig. 1B, compare lanes 1-3 with
lanes 7-9). Rev1 inserted a C residue opposite uracil,
8-oxoG, and m6G, whereas opposite an abasic site in addition to a C,
Rev1 inserted some G and T as well (Fig. 1A).
DNA Synthesis by Rev1 on a G-containing Template--
Next, we
examined whether Rev1 could synthesize DNA on a template containing a
string of Gs in a template-specific manner, and we found that Rev1
could in fact synthesize DNA almost to the end of this template,
specifically inserting a C residue (Fig. 2A, lanes 5 and
6). This observation raised the possibility that instead of
transferring only one nucleotide in a single DNA binding event, Rev1
was able to polymerize DNA, like DNA polymerases, in a G
template-dependent manner and could incorporate more than one nucleotide per DNA binding event. We measured the processivity of
Rev1 on a DNA substrate containing a string of 11 Gs toward the 5' end
of the template right after the primer:template junction (Fig.
2B). Processivity is a measure of how many deoxynucleotides a DNA polymerase incorporates in a single DNA binding event. To ensure
that we were observing deoxynucleotide incorporation resulting from a
single DNA binding event, we monitored DNA synthesis by Rev1 in the
presence of excess of nonradiolabeled DNA substrate as a trap (Fig.
2B). The reactions were performed by first preincubating Rev1 with the radiolabeled DNA substrate without deoxynucleotide. DNA
synthesis was initiated by the addition of increasing concentrations of
all four deoxynucleotides (Fig. 2B, lanes 1-7)
or a mixture of 100-fold excess of the same but nonradiolabeled DNA
substrate and all four deoxynucleotides to the reaction (Fig.
2B, lanes 8-14). Under these conditions, any
Rev1 molecule that dissociates from the labeled DNA substrate will be
trapped by the excess of nonradiolabeled DNA. The effectiveness of the
trap was verified by first preincubating Rev1 with the radiolabeled DNA
substrate and the excess nonlabeled DNA followed by the addition of
deoxynucleotides. The lack of DNA synthesis in this sample shows that
the 100-fold excess of nonlabeled DNA is sufficient to trap all Rev1
molecules (Fig. 2B, lane 15). In the presence of
saturating nucleotide concentration, Rev1 copied the template DNA,
incorporating as many as nine nucleotides in a single DNA binding event
(Fig. 2B, lane 14).
The percentage of active Rev1 molecules was calculated from the
intensities of bands in Fig. 2B, lane 14 (see
"Materials and Methods"), and the percentage of Rev1 molecules
adding at least one deoxynucleotide was set as 100%. The percentage of
active Rev1 molecules decreased after the addition of each subsequent nucleotide because of the dissociation of some fraction of Rev1 molecules from DNA (Fig. 2C). The processivity of Rev1,
defined quantitatively as the probability (Pn) for
each deoxynucleotide incorporation event n that Rev1 will
move ahead to incorporate the next nucleotide n + 1 rather
than dissociate from the DNA template, on this DNA substrate is
0.61. Thus, after each nucleotide incorporation, on average 61%
of the bound Rev1 molecules incorporate at least one additional
deoxynucleotide, whereas 39% dissociate from the DNA substrate, which
leads to an incorporation of 1.6 nucleotides per DNA binding event on
the average. Thus, Rev1 shares the low processivity
characteristic of the Y family of DNA polymerases.
Steady-state Kinetic Analysis of Nucleotide Insertion by Rev1
Opposite Undamaged Bases--
Rev1 protein has been designated as a
deoxycytidyltransferase based upon its ability, examined at saturating
nucleotide concentrations, to insert a C nucleotide more efficiently
opposite a template abasic site, a noninstructional lesion, than
opposite template G (8). This designation may suggest that Rev1 does
not monitor the information of the template strand and is not very
efficient at distinguishing between correct and incorrect nucleotide
insertion. To characterize further the specificity of the DNA
polymerization reaction catalyzed by Rev1, we analyzed the steady-state
kinetics of nucleotide incorporation opposite undamaged and damaged
template residues by Rev1. The kinetics of insertion of a single
deoxynucleotide opposite undamaged G, A, T, or C were determined as a
function of deoxynucleotide concentration under steady-state
conditions. From the kinetics of deoxynucleotide incorporation, the
steady-state apparent Km and
kcat values for each deoxynucleotide were
obtained from the curve fitted to the Michaelis-Menten equation. The
frequency of nucleotide misincorporation, finc, was calculated as the ratio of the efficiency
(kcat/Km) of incorrect
nucleotide incorporation to the efficiency
(kcat/Km) of correct
nucleotide incorporation (Table
I).
As indicated by the kcat/Km
values, Rev1 incorporates a C opposite template G ~130-500-fold more
efficiently than opposite template A, T, or C. Opposite template G,
Rev1 incorporates the correct C ~500-, 1000-, or 15000-fold more
efficiently than it inserts the incorrect G, T, or A, respectively
(Table I). This finding indicates that while inserting nucleotides
opposite undamaged template bases, Rev1 uses the information of the
template and discriminates between the correct and incorrect nucleotides.
Steady-state Kinetic Analysis of Nucleotide Incorporation by Rev1
Opposite Damaged Bases--
Next, we compared the efficiencies of
deoxynucleotide insertion opposite an undamaged G, an abasic site, an
m6G, and an 8-oxoG (Fig. 3). As judged
from the kcat/Km values, Rev1
inserts a G, an A, a T, or a C ~4-, 6-, 3-, 24-fold less efficiently, respectively, opposite an AP site than opposite an undamaged G (Table
1). In another sequence context, Rev1 incorporated a C residue opposite
an AP site ~27-fold less efficiently than opposite an undamaged G
template residue (Fig. 3 and Table I). Rev1 inserted a C residue
opposite an m6G lesion, ~39-fold less efficiently, and opposite an
8-oxoG lesion ~370-fold less efficiently than opposite an undamaged G
(Fig. 3 and Table I). Thus, Rev1 is sensitive to DNA lesions, and its
activity is inhibited on lesion containing DNA substrates.
Here, we show that Rev1 is most efficient at inserting a C
opposite template G, and Rev1 replicates a poly(dG) template DNA by
specific insertion of Cs, and on this DNA, it incorporates 1.6 nucleotides per DNA binding event on the average. Rev1 misincorporates nucleotides opposite template G with a frequency of
~10 In contrast to a previous study that reported that Rev1 was ~5-fold
more efficient at inserting a C opposite an abasic site than opposite
template G (8), we found that Rev1 is over 20-fold better at inserting
C opposite undamaged G than opposite an abasic site. Furthermore, our
steady-state kinetic studies show that the more proficient insertion of
C opposite template G than that opposite an abasic site results from a
reduction in the apparent Km for the nucleotide,
whereas the kcat stays approximately the same
(Table I). Because the previous study was qualitative performed with a
single saturating concentration of the nucleotide, one would not have
detected the differences in Km that we report here.
We also examined Rev1 for its ability to insert a C opposite two other
DNA lesions, m6G and 8-oxoG. Rev1 inserted a C opposite m6G
approximately 40-fold less efficiently than opposite an undamaged G,
and in this case as well, the inefficient insertion of C opposite m6G
was almost entirely attributed to an increase in the
Km for the nucleotide (Table I). Rev1 was very
inefficient at inserting a C opposite 8-oxoG, because it did so
~370-fold less efficiently than the insertion of C opposite
template G. This poor nucleotide insertion opposite 8-oxoG results from
an ~100-fold increase in the Km for the nucleotide
and from an ~5-fold decrease in the kcat for
the enzyme (Table I). Thus, Rev1 is most conducive for nucleotide
incorporation when bound to the template G than when bound to the other
undamaged template nucleotides or to DNA lesions. This finding may
suggest that Rev1 more readily adopts a configuration suitable for
binding the C nucleotide when it is bound to the G template than when
bound to the other template nucleotides.
The proficient ability of Rev1 to insert a C opposite template G and to
replicate poly(dG) DNA in a template-specific manner implies that Rev1
is a G template-specific DNA polymerase. Although Rev1 can also
incorporate a C opposite templates T, A, and C, it does so with a
frequency of ~10 Rev1 and Pol Pre-steady-state kinetic analyses of Pol In conclusion, our results indicate that Rev1 is a G template-specific
DNA polymerase. However, because of its inability to incorporate all
four deoxynucleotides during the synthesis reaction, we consider it
inappropriate to assign it a Greek letter nomenclature used for
eukaryotic DNA polymerases.
*
This work was supported by National Institutes of Health
Grant GM19261.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, February 15, 2002, DOI 10.1074/jbc.M112146200
2
L. Haracska, S. Prakash, and L. Prakash,
unpublished observations.
The abbreviations used are:
Pol, polymerase;
nt, nucleotide;
AP, abasic site;
m6G, O6-methylguanine;
8-oxoG, 8-oxoguanine.
Yeast Rev1 Protein Is a G Template-specific DNA Polymerase*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
in mutagenic
trans-lesion synthesis. Because of the reported
preferential incorporation of a C residue opposite an abasic site, Rev1
has been referred to as a deoxycytidyltransferase. Here, we use
steady-state kinetics to examine nucleotide incorporation by Rev1
opposite undamaged and damaged template residues. We show that Rev1
specifically inserts a C residue opposite template G, and it is ~25-,
40-, and 400-fold less efficient at inserting a C residue opposite an
abasic site, an O6-methylguanine, and an
8-oxoguanine lesion, respectively. Rev1 misincorporates G, A, and T
residues opposite template G with a frequency of ~10
3
to 10
4. Consistent with this finding, Rev1 replicates DNA
containing a string of Gs in a template-specific manner, but it has a
low processivity incorporating 1.6 nucleotides per DNA binding event on
the average. From these observations, we infer that Rev1 is a G
template-specific DNA polymerase.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
, which incorporates all
four deoxynucleotides in a template-specific manner and has the ability
to replicate through a variety of DNA lesions (4-7), the Rev1 protein
has been reported to preferentially incorporate a C residue opposite an
abasic site (8). Rev1 also could incorporate a C residue opposite
templates G and A but was only ~20 and 10% as effective, respectively, in these reactions as the insertion opposite an abasic
site (8). Because of the preferential ability of Rev1 to insert a C
residue opposite an abasic site, a noninformational DNA lesion, this
activity has been referred to as a deoxycytidyltransferase.
(9) in the
mutagenic bypass of UV lesions, polymerase
(Pol
)1 promotes the
error-free bypass of UV-induced cyclobutane pyrimidine dimers. Pol
replicates through a cis-syn-thymine-thymine (T-T) dimer
with the same efficiency and accuracy as through undamaged Ts (10, 11),
and genetic studies in yeast have also indicated a role for Pol
in
the error-free bypass of cyclobutane dimers formed at 5'-TC-3'
and 5'-CC-3' sites (12). Pol
, which is a member of the Pol
family, promotes lesion bypass by extending from the nucleotide
inserted by another DNA polymerase opposite the 3'-T of a T-T dimer or
a (6-4)TT photoproduct (13, 14). Although the Rev1 protein is almost as
indispensable for UV mutagenesis as is Pol
, its C-transferase
activity is not needed for this function, because C insertion occurs
only rarely opposite the UV lesions in yeast (15, 16) and inactivation
of this biochemical activity has no impact on UV
mutagenesis.2
(17), and it depends upon the sequential action of two DNA polymerases
in which one inserts the nucleotide opposite the abasic site and Pol
subsequently extends from the inserted nucleotide (18). Although Rev1
is able to insert a C residue opposite an abasic site in an in
vitro reaction, the inactivation of Rev1 C-transferase activity
causes no significant reduction in the incidence of mutations resulting
from the bypass of abasic sites (18). This result is probably because
of the fact that many different polymerases, including Pol
and
Pol
, contribute to the insertion step (18, 19). The indispensability
of the Rev1 protein, but not of its C-transferase activity, for the
mutagenic bypass of UV lesions as well as that of abasic sites has
suggested that the primary role of Rev1 in the mutagenic bypass of
these lesions is structural. In this role, Rev1 could act as an
intermediary, promoting the assembly of Pol
with Pol
stalled at a
lesion site (18).
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (32K):
[in a new window]
Fig. 1.
Nucleotide incorporation by Rev1
protein. A, Specificity of deoxynucleotide
incorporation by Rev1 protein. Nucleotide sequence adjacent to the
primer:template junction is shown for each of the DNA substrates. Rev1
(3 nM) was incubated with the DNA substrate (10 nM) in a Tris buffer in the absence (-) or presence of a
single (G, A, T, or C) or all four deoxynucleotides (N) (100 µM each) for 10 min at 30 °C. The concentration of
product formed (in nM) was determined by phosphorimaging;
dashes indicate that no detectable product was formed.
B, deoxynucleotide incorporation by Rev1 opposite various
template G residues in different sequence contexts. DNA substrates (10 nM) were incubated with Rev1 (5 nM) in a
phosphate buffer for 10 min at 30 °C.

View larger version (22K):
[in a new window]
Fig. 2.
DNA polymerization reaction on a poly(G) DNA
template by Rev1. A, specificity of deoxynucleotide
incorporation by Rev1 opposite Gs in a poly(G) template. Nucleotide
sequence adjacent to the primer:template junction is shown. DNA
substrate (10 nM) was incubated with Rev1 (3 nM) in a phosphate buffer in the absence (-) or presence of
a single (G, A, T, or C) or all four deoxynucleotides (N) (100 µM each) for 10 min at 30 °C. B, nucleotide
incorporation by Rev1 resulting from a single DNA binding event. Rev1
(3 nM) was preincu- bated with the DNA substrate (10 nM) without
deoxynucleotides for 5 min at 30 °C. Reactions were initiated by
adding all four deoxynucleotides at increasing concentration (0.5-100
µM each) or all four deoxynucleotides plus 100-fold
excess of nonradiolabeled DNA substrate as a trap followed by 10-min
incubation at 30 °C. As the control to demonstrate the effectiveness
of the trap, Rev1 was preincubated with the DNA trap and the
primer-template substrate before the addition of dNTPs (lane
15). C, processivity of Rev1. The percentage of Rev1
molecules incorporating at least n deoxynucleotides was
calculated from quantitation of the intensity of each of the bands in
Fig. 2B, lane 14, as described under "Materials
and Methods." The percentage of Rev1 adding at least one
deoxynucleotide was set as 100%.
Steady-state kinetic parameters of nucleotide insertion reactions
catalyzed by yeast Rev1 protein

View larger version (37K):
[in a new window]
Fig. 3.
Steady-state kinetic analysis of
deoxynucleotide incorporation by Rev1. A, dCTP
incorporation opposite an undamaged G, an AP site, an m6G, and an
8-oxoG. Rev1 (1 nM) was incubated with the primer:template
DNA (10 nM) and with the indicated concentrations of dCTP
for 10 min at 30 °C. B, quantitation of dCTP
incorporation reactions. The rate of incorporation is graphed as a
function of dCTP concentration, and the data are fit to the
Michaelis-Menten equation. The kcat and
Km parameters obtained from the fit are listed in
Table I.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
3 to 10
4. In its fidelity and
processivity on the G template, Rev1 resembles Pol
, which
misincorporates nucleotides opposite G with a similar frequency and
displays a similar low processivity (20).
2 to 10
3. In this regard
also, Rev1 resembles Pol
, which misincorporates a C opposite these
templates with a similar frequency (20). However, in its specificity
for primarily incorporating a C opposite template G, Rev1 is more
similar to human Pol
(13, 23), another member of the Y polymerase
family, than to Pol
. Pol
is most efficient at inserting the
correct nucleotide T opposite template A, and opposite this template,
it misincorporates with a frequency of 10
4 to
10
6. Although Pol
incorporates the correct nucleotides
C and G opposite templates G and C, respectively, it is much less
efficient and accurate opposite these templates than opposite template
A (13). Pol
is highly inefficient at inserting nucleotides opposite
template T, and moreover, it incorporates a G opposite this template
~10-fold better than an A (13). Thus, Pol
is most efficient and
accurate on template A, and on the other three template nucleotides, it is much less efficient and accurate. However, in striking contrast to
Pol
, Rev1 is unable to insert the other three nucleotides with any
reasonable efficiency, and its ability to primarily insert a C
represents the most extreme deviation from normal polymerase behavior.
resemble each other in their ability to insert
nucleotides opposite an abasic site. However, in contrast to the
specific insertion of a C opposite this lesion by Rev1, Pol
primarily incorporates an A, and to a lesser extent, a G opposite this
lesion site (13). The specificity of Rev1 for C insertion opposite an
abasic site is enigmatic, because when a pyrimidine is positioned
opposite the abasic site, both the pyrimidine and the abasic sugar are
extrahelical and the helix collapses (24). By contrast, when an A is
positioned opposite the AP site, the DNA retains the B-form, and both
the unpaired A and the abasic residues remain intrahelical (24-26).
Consequently, most DNA polymerases tend to insert an A opposite an
abasic site (27). At low temperatures, a G opposite an abasic site is
also predominantly intrahelical, and similar to Pol
, Pol
inserts
a G or an A opposite an abasic site (19).
have indicated a two-step
nucleotide binding mechanism in which the DNA bound polymerase first
binds the nucleotide and then undergoes the rate-limiting induced fit
conformational change prior to the chemical step of phosphodiester bond
formation (28). The preference of Rev1 to insert a C opposite template
G and also opposite DNA lesions might suggest that Rev1 undergoes the
induced fit conformational change prior to the chemical step of
phosphodiester bond formation far more readily when a C nucleotide is
bound in the active site of the enzyme. In the presence of nucleotides
other than C, such a conformational change may not occur or it becomes
too slow. The over 20-fold preferential incorporation of a C opposite
template G than opposite an abasic site and even a greater inhibition
of C insertion opposite 8-oxoG and m6G lesions additionally suggest that the presence of G in the template is also important for such a
putative conformational change to occur.
![]()
FOOTNOTES
To whom correspondence should be addressed: Sealy Center for
Molecular Science, University of Texas Medical Branch, 6.104 Medical
Research Bldg., 11th and Mechanic St., Galveston, TX
77555-1061. Tel.: 409-747-8601; Fax: 409-747-8608; E-mail:
lprakash@scms.utmb.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Ohmori, H.,
Friedberg, E. C.,
Fuchs, R. P. P.,
Goodman, M. F.,
Hanaoka, F.,
Hinkle, D.,
Kunkel, T. A.,
Lawrence, C. W.,
Livneh, Z.,
Nohmi, T.,
Prakash, L.,
Prakash, S.,
Todo, T.,
Walker, G. C.,
Wang, Z.,
and Woodgate, R.
(2001)
Mol. Cell
8,
7-8[CrossRef][Medline]
[Order article via Infotrieve] 2.
Johnson, R. E.,
Washington, M. T.,
Prakash, S.,
and Prakash, L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
12224-12226 3.
Goodman, M. F.,
and Tippin, B.
(2000)
Curr. Opin. Genet. Dev.
10,
162-168[CrossRef][Medline]
[Order article via Infotrieve] 4.
Johnson, R. E.,
Prakash, S.,
and Prakash, L.
(1999)
Science
283,
1001-1004 5.
Haracska, L., Yu, S.-L.,
Johnson, R. E.,
Prakash, L.,
and Prakash, S.
(2000)
Nat. Genet.
25,
458-461[CrossRef][Medline]
[Order article via Infotrieve] 6.
Haracska, L.,
Prakash, S.,
and Prakash, L.
(2000)
Mol. Cell. Biol.
20,
8001-8007 7.
Minko, I. G.,
Washington, M. T.,
Prakash, L.,
Prakash, S.,
and Lloyd, R. S.
(2001)
J. Biol. Chem.
276,
2517-2522 8.
Nelson, J. R.,
Lawrence, C. W.,
and Hinkle, D. C.
(1996)
Nature
382,
729-731[CrossRef][Medline]
[Order article via Infotrieve] 9.
Nelson, J. R.,
Lawrence, C. W.,
and Hinkle, D. C.
(1996)
Science
272,
1646-1649[Abstract] 10.
Johnson, R. E.,
Washington, M. T.,
Prakash, S.,
and Prakash, L.
(2000)
J. Biol. Chem.
275,
7447-7450 11.
Washington, M. T.,
Johnson, R. E.,
Prakash, S.,
and Prakash, L.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
3094-3099 12.
Yu, S.-L.,
Johnson, R. E.,
Prakash, S.,
and Prakash, L.
(2001)
Mol. Cell. Biol.
21,
185-188 13.
Johnson, R. E.,
Washington, M. T.,
Haracska, L.,
Prakash, S.,
and Prakash, L.
(2000)
Nature
406,
1015-1019[CrossRef][Medline]
[Order article via Infotrieve] 14.
Johnson, R. E.,
Haracska, L.,
Prakash, S.,
and Prakash, L.
(2001)
Mol. Cell. Biol.
21,
3558-3563 15.
Gibbs, P. E. M.,
Kilbey, B. J.,
Banerjee, S. K.,
and Lawrence, C. W.
(1993)
J. Bacteriol.
175,
2607-2612 16.
Gibbs, P. E. M.,
Borden, A.,
and Lawrence, C. W.
(1995)
Nucleic Acids Res.
23,
1919-1922 17.
Johnson, R. E.,
Torres-Ramos, C. A.,
Izumi, T.,
Mitra, S.,
Prakash, S.,
and Prakash, L.
(1998)
Genes Dev.
12,
3137-3143 18.
Haracska, L.,
Unk, I.,
Johnson, R. E.,
Johansson, E.,
Burgers, P. M. J.,
Prakash, S.,
and Prakash, L.
(2001)
Genes Dev.
15,
945-954 19.
Haracska, L.,
Kondratick, C. M.,
Unk, I.,
Prakash, S.,
and Prakash, L.
(2001)
Mol. Cell
8,
407-415[CrossRef][Medline]
[Order article via Infotrieve] 20.
Washington, M. T.,
Johnson, R. E.,
Prakash, S.,
and Prakash, L.
(1999)
J. Biol. Chem.
274,
36835-36838 21.
Creighton, S.,
Bloom, L. B.,
and Goodman, M. F.
(1995)
Methods Enzymol.
262,
232-256[Medline]
[Order article via Infotrieve] 22.
Goodman, M. F.,
Creighton, S.,
Bloom, L. B.,
and Petruska, J.
(1993)
Crit. Rev. Biochem. Mol. Biol.
28,
83-126[Medline]
[Order article via Infotrieve] 23.
Tissier, A.,
McDonald, J. P.,
Frank, E. G.,
and Woodgate, R.
(2000)
Genes Dev.
14,
1642-1650 24.
Cuniasse, P.,
Fazakerley, G. V.,
Guschlbauer, W.,
Kaplan, B. E.,
and Sowers, L. C.
(1990)
J. Mol. Biol.
213,
303-314[CrossRef][Medline]
[Order article via Infotrieve] 25.
Cuniasse, P.,
Sowers, L. C.,
Eritja, R.,
Kaplan, B.,
Goodman, M. F.,
Cognet, J. A. H.,
LeBret, M.,
Guschlbauer, W.,
and Fazakerley, G. V.
(1987)
Nucleic Acids Res.
15,
8003-8022 26.
Kalnik, M. W.,
Chang, C.-N.,
Grollman, A. P.,
and Patel, D. J.
(1988)
Biochemistry
27,
924-931[CrossRef][Medline]
[Order article via Infotrieve] 27.
Strauss, B. S.
(1991)
Bioessays
13,
79-84[CrossRef][Medline]
[Order article via Infotrieve] 28.
Washington, M. T.,
Prakash, L.,
and Prakash, S.
(2001)
Cell
107,
917-927[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
V. Pages, A. Bresson, N. Acharya, S. Prakash, R. P. Fuchs, and L. Prakash Requirement of Rad5 for DNA Polymerase {zeta}-Dependent Translesion Synthesis in Saccharomyces cerevisiae Genetics, September 1, 2008; 180(1): 73 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Choi and F. P. Guengerich Kinetic Analysis of Translesion Synthesis Opposite Bulky N2- and O6-Alkylguanine DNA Adducts by Human DNA Polymerase REV1 J. Biol. Chem., August 29, 2008; 283(35): 23645 - 23655. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pages, R. E. Johnson, L. Prakash, and S. Prakash Mutational specificity and genetic control of replicative bypass of an abasic site in yeast PNAS, January 29, 2008; 105(4): 1170 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Acharya, L. Haracska, S. Prakash, and L. Prakash Complex Formation of Yeast Rev1 with DNA Polymerase {eta} Mol. Cell. Biol., December 1, 2007; 27(23): 8401 - 8408. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takahashi, A. N. Sakamoto, A. Tanaka, and K. Shimizu AtREV1, a Y-Family DNA Polymerase in Arabidopsis, Has Deoxynucleotidyl Transferase Activity in Vitro Plant Physiology, November 1, 2007; 145(3): 1052 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wood, P. Garg, and P. M. J. Burgers A Ubiquitin-binding Motif in the Translesion DNA Polymerase Rev1 Mediates Its Essential Functional Interaction with Ubiquitinated Proliferating Cell Nuclear Antigen in Response to DNA Damage J. Biol. Chem., July 13, 2007; 282(28): 20256 - 20263. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Acharya, R. E. Johnson, S. Prakash, and L. Prakash Complex Formation with Rev1 Enhances the Proficiency of Saccharomyces cerevisiae DNA Polymerase {zeta} for Mismatch Extension and for Extension Opposite from DNA Lesions Mol. Cell. Biol., December 15, 2006; 26(24): 9555 - 9563. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D'Souza and G. C. Walker Novel Role for the C Terminus of Saccharomyces cerevisiae Rev1 in Mediating Protein-Protein Interactions Mol. Cell. Biol., November 1, 2006; 26(21): 8173 - 8182. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Masuda and K. Kamiya Role of Single-stranded DNA in Targeting REV1 to Primer Termini J. Biol. Chem., August 25, 2006; 281(34): 24314 - 24321. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Haracska, I. Unk, L. Prakash, and S. Prakash Ubiquitylation of yeast proliferating cell nuclear antigen and its implications for translesion DNA synthesis PNAS, April 25, 2006; 103(17): 6477 - 6482. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Murakumo, S. Mizutani, M. Yamaguchi, M. Ichihara, and M. Takahashi Analyses of ultraviolet-induced focus formation of hREV1 protein Genes Cells, March 1, 2006; 11(3): 193 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Abdulovic and S. Jinks-Robertson The in Vivo Characterization of Translesion Synthesis Across UV-Induced Lesions in Saccharomyces cerevisiae: Insights Into Pol{zeta}- and Pol{eta}-Dependent Frameshift Mutagenesis Genetics, March 1, 2006; 172(3): 1487 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Garg and P. M. Burgers Ubiquitinated proliferating cell nuclear antigen activates translesion DNA polymerases {eta} and REV1 PNAS, December 20, 2005; 102(51): 18361 - 18366. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sabbioneda, B. K. Minesinger, M. Giannattasio, P. Plevani, M. Muzi-Falconi, and S. Jinks-Robertson The 9-1-1 Checkpoint Clamp Physically Interacts with Pol{zeta} and Is Partially Required for Spontaneous Pol{zeta}-dependent Mutagenesis in Saccharomyces cerevisiae J. Biol. Chem., November 18, 2005; 280(46): 38657 - 38665. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Acharya, L. Haracska, R. E. Johnson, I. Unk, S. Prakash, and L. Prakash Complex Formation of Yeast Rev1 and Rev7 Proteins: a Novel Role for the Polymerase-Associated Domain Mol. Cell. Biol., November 1, 2005; 25(21): 9734 - 9740. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Nair, R. E. Johnson, L. Prakash, S. Prakash, and A. K. Aggarwal Rev1 Employs a Novel Mechanism of DNA Synthesis Using a Protein Template Science, September 30, 2005; 309(5744): 2219 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Wolfle, M. T. Washington, E. T. Kool, T. E. Spratt, S. A. Helquist, L. Prakash, and S. Prakash Evidence for a Watson-Crick Hydrogen Bonding Requirement in DNA Synthesis by Human DNA Polymerase {kappa} Mol. Cell. Biol., August 15, 2005; 25(16): 7137 - 7143. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okuda, X. Lin, J. Trang, and S. B. Howell Suppression of hREV1 Expression Reduces the Rate at Which Human Ovarian Carcinoma Cells Acquire Resistance to Cisplatin Mol. Pharmacol., June 1, 2005; 67(6): 1852 - 1860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Jansen, A. Tsaalbi-Shtylik, P. Langerak, F. Calléja, C. M. Meijers, H. Jacobs, and N. de Wind The BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis Nucleic Acids Res., January 13, 2005; 33(1): 356 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Washington, I. G. Minko, R. E. Johnson, L. Haracska, T. M. Harris, R. S. Lloyd, S. Prakash, and L. Prakash Efficient and Error-Free Replication past a Minor-Groove N2-Guanine Adduct by the Sequential Action of Yeast Rev1 and DNA Polymerase {zeta} Mol. Cell. Biol., August 15, 2004; 24(16): 6900 - 6906. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Guo, Z. Xie, H. Shen, B. Zhao, and Z. Wang Translesion synthesis of acetylaminofluorene-dG adducts by DNA polymerase {zeta} is stimulated by yeast Rev1 protein Nucleic Acids Res., February 11, 2004; 32(3): 1122 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Covo, L. Blanco, and Z. Livneh Lesion Bypass by Human DNA Polymerase {micro} Reveals a Template-dependent, Sequence-independent Nucleotidyl Transferase Activity J. Biol. Chem., Janu |